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ABSTRACT LyticbacteriophagesarehypothesizedtocontributetotheseasonalityanddurationofcholeraepidemicsinBang-
ladesh.However,thebacteriophagescontributingtothisphenomenonhaveyettobecharacterizedatamoleculargeneticlevel.
Inthisstudy,weisolatedandsequencedthegenomesof15bacteriophagesfromstoolsamplesfromcholerapatientsspanninga
10-yearsurveillanceperiodinDhaka,Bangladesh.Ourresultsindicatethatasinglenovelbacteriophagetype,designatedICP1
(fortheInternationalCentreforDiarrhoealDiseaseResearch,Bangladeshcholeraphage1)ispresentinallstoolsamplesfrom
cholerapatients,whiletwootherbacteriophagetypes,onenovel(ICP2)andoneT7-like(ICP3),aretransient.ICP1isamember
oftheMyoviridaefamilyandhasa126-kilobasegenomecomprising230openreadingframes.Comparativesequenceanalysisof
ICP1andrelatedisolatesfromthistimeperiodindicatesahighlevelofgeneticconservation.TheubiquitouspresenceofICP1in
cholerapatientsandtheﬁndingthattheO1antigenoflipopolysaccharide(LPS)servesastheICP1receptorsuggestthatICP1is
extremely well adapted to predation of human-pathogenic V. cholerae O1.
IMPORTANCE The severe diarrheal disease cholera is caused by the bacterium Vibrio cholerae, which can be transmitted to hu-
mans from the aquatic environment. Factors that affect V. cholerae in the environment can impact the occurrence of cholera
outbreaks;oneofthesefactorsisthoughttobethepresenceofbacterialviruses,orbacteriophages.Bacteriophagesthatpreyon
V. cholerae in the environment, and potentially in humans, have not been extensively genetically characterized. Here, we isolated
andsequencedthegenomesofbacteriophagesfromcholerapatientstoolsamplescollectedovera10-yearperiodinDhaka,Ban-
gladesh,aregionthatsuffersfromregularcholeraoutbreaks.Wedescribeauniquebacteriophagepresentinallsamples,inferits
evolutionbysequencingmultipleisolatesfromdifferentpatientsovertime,andidentifythehostreceptorthatshowsthatthe
bacteriophage speciﬁcally predates the serogroup of V. cholerae responsible for the majority of disease occurrences.
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C
holera is a substantial health burden worldwide and is en-
demic in many parts of South Asia, Africa, South America,
and Central America (1). Cholera epidemics can occur both in
areas where cholera is endemic and areas where it is not endemic;
the current outbreak in Haiti (2), a country that has not seen the
disease in over a century, highlights the ongoing vulnerability of
underdeveloped and tragedy-struck nations to explosive disease.
Toxigenic Vibrio cholerae strains belonging to O1 and O139 sero-
groupsarethecausativeagentsofepidemicandpandemiccholera
(3). V. cholerae O1 biotype El Tor, which can be distinguished by
serotype (Ogawa and Inaba [4]) is the current leading cause of
cholera both worldwide and regionally in Bangladesh (5, 6).
V. cholerae O139, although it accounts for a much lower propor-
tionofcholera,continuestocirculateandcausediseasewithO1El
Tor. Cholera is characterized by acute secretory diarrhea that can
rapidlyleadtoseveredehydrationanddeathifleftuntreated.Tox-
igenicV.choleraeispresentintheenvironmentasamemberofthe
aquatic ecosystem and can emerge to cause disease in humans (7,
8).Factorsimpactingtheinterepidemicpersistenceandecologyof
V. cholerae in the aquatic environment can have great impact on
the transmission and virulence of this organism (8–12). One en-
vironmental factor hypothesized to have an important role in
shaping cholera outbreaks is the presence of V. cholerae lytic bac-
teriophages.
The dynamic between cholera incidence and lytic phages has
recently been documented at the International Centre for Diar-
rhoeal Disease Research, Bangladesh (ICDDR,B) located in
Dhaka,Bangladesh.InthisregionofSouthAsia,wherecholerahas
long been endemic, two distinct peaks of cholera occur each year,
and each peak is inversely correlated with the presence of lytic
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of lytic phage in the environment was observed to coincide with
the increasing excretion of phage in stool samples from cholera
patients (13). These observations led to the prediction that as
V.choleraeincreasesindensityintheenvironmentasanoutbreak
proceeds,thelevelofpredationbylyticphagereachesaheightthat
promotes a decline in the outbreak (13, 14). In addition, experi-
ments addressing the impact of lytic phage on growth of V. chol-
erae in the infant mouse infection model indicate that phage can
dramatically reduce the load of V. cholerae in the small intestine
(15, 16), which would contribute further to a decline in the out-
breakifthephagebehavessimilarlyinhumans.However,thelytic
phageshypothesizedtoplaysuchacriticalroleinthedynamicsof
cholera outbreaks in Bangladesh have not been genetically char-
acterized,andthediversityofphagesinvolvedinpotentiallymod-
ulating cholera outbreaks in this and other regions is unclear.
In this study, we isolated and sequenced the genomes of 15
phages from cholera patient stool samples collected at the
ICDDR,B over a 10-year surveillance period. Our results indicate
that a single novel phage type, designated ICP1 (for ICDDR,B
cholera phage 1), is present in all cholera patient stool samples
analyzed,whiletwounrelatedphages(ICP2andICP3)haveover-
lapped with ICP1 for distinct periods.
RESULTS
Isolation of phages. Since 2000, there has been an ongoing NIH-
funded prospective study of cholera at the ICDDR,B, in which
stool samples are collected from patients for analysis and cryo-
preservation. These protocols have been reviewed and approved
by both the ethical review committee at the ICDDR,B and the
institutional review board at Massachusetts General Hospital.
Thirty-onestoolsamplesspanninga10-yearperiodbetween2001
and 2010 were obtained and tested for the presence of phage ca-
pable of forming plaques on V. cholerae O1 El Tor. Of the 15
phages studied, three were previously isolated (15), while the re-
maining 12 were isolated in this study. Sequencing of the 15
phages revealed the presence of three distinct phage types desig-
nated ICP1, ICP2, and ICP3 (Table 1). The host range of ICP1 is
limitedtoV.choleraeO1,whilethehostrangesforICP2andICP3
alsoincludenon-O1V.choleraestrains.Speciﬁcally,ICP2iscapa-
ble of forming plaques on V. cholerae O139 strain MO10, and
ICP3iscapableofformingplaquesonanon-O1,non-O139strain
CR034-24. Between one and seven additional isolates of each
phage type were sequenced and based on the high-level DNA se-
quencehomologyweredesignatedrelatedisolates.Thephageiso-
late from each type isolated at the earliest point in time was des-
ignated the prototype phage (ICP1, ICP2, and ICP3) and was
analyzed in a detailed manner at the genomic level. The GenBank
accession numbers for all phages are provided in Table S1 in the
supplemental material.
PrevalenceofICP1-,ICP2-,andICP3-relatedphagesinclin-
ical specimens. Primers (see Table S2 in the supplemental mate-
rial)designedfortheDNApolymeraseineachphagewereusedto
screen all stool samples by PCR; samples were conﬁrmed positive
for the presence of ICP2 or ICP3 with one additional primer set
each. Three additional sets of primers designed to amplify poly-
morphic loci in ICP1-related phages were used to conﬁrm the
prevalence of these phages in all stool samples (Table 2).
ICP1 genome. ICP1 is an unclassiﬁed member of the Myoviri-
dae family, with an icosahedral head that is 86 nm long and a tail
that is 106 nm long and 17 nm wide (Fig. 1A). ICP1 is morpho-
logically unrelated to any Vibrio phages known (17), but it closely
resembles a phage of Salinivibrio (18). The ICP1 genome is
125,956bpwithanaverageGCcontentof37%(Table1),which
isapproximately10%percentlowerthanthatofitsV.choleraeO1
host (19). The difference in GC content between ICP1 and
V. cholerae is apparent in their respective codon usage patterns
(see Table S3 in the supplemental material). No tRNAs were
TABLE 1 General characteristics of the sequenced and annotated V. cholerae phages isolated from cholera patients at the ICDDR,B between 2001
and 2010
Phage
Taxonomic
family
Genome
size
(bp)
GC
content
(%)
%o f
genome coding
for proteins
No. of
predicted
CDSs
% CDSs
similar to
known
proteins
% CDSs
similar to
conserved
hypothetical
proteins
% CDSs
with homology
to hypothetical
proteins
No. of
fully
sequenced
isolates
ICP1 Myoviridae 125,956 37.1 88.4 230 12 13 75 8
ICP2 Podoviridae 49,675 42.7 93.7 73 19 18 63 2
ICP3 Podoviridae 39,162 42.9 91.9 54 48 33 19 5
TABLE 2 Detection of V. cholerae phages ICP1, ICP2, and ICP3 in cholera patient stool samples collected at the ICDDR,B between 2001 and 2010
Phage
Presence of phage detected in individual stool samples collected in the following yra:
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
S1 S2 S3 S1 S2 S3 S1 S2 S3 S1 S2 S3 S1 S2 S3 S1 S2 S1 S2 S3 S1 S2 S3 S1 S2 S3 S1 S2 S3
ICP1 
   
ICP2     

ICP3    
  
a The presence of phage detected in individual patient stool samples S1, S2, and S3 collected between 2001 and 2010 is indicated as follows: , phage detected by PCR; , phage
isolated from stool sample.
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lates.
A total of 230 predicted coding sequences (CDSs) were identi-
ﬁed,aswellas16predictedpromotersandsevenrho-independent
transcriptionalterminators(Fig.2).ThemajorityofdeﬁnedCDSs
had no identiﬁable homologue (75%). In addition, 13% of CDSs
showed homology to hypothetical proteins, leaving only 12% of
the entire ICP1 genome that could be assigned putative function
(Table 1). Of the CDSs with homology to proteins from phages,
therewerenomajoritywithsigniﬁcantsimilaritytooneparticular
phage, indicating that ICP1 is truly a unique phage of previously
sequenced phages.
HalfoftheCDSswithpredictedfunctions(14/28)areinvolved
innucleotidemetabolism,replication,recombination,andrepair.
ICP1 carries genes encoding a DNA polymerase (DNAP) (open
reading frame [ORF] 58) (Fig. 2), RNase H (ORF 55), primase/
helicase (ORF 57), helicase (ORF 147), a recombination-
associated protein (ORF 173), exonuclease (ORF 176), and DNA
ligase (ORF 215). CDSs involved in nucleotide metabolism are
nrdDG(ORF113and114),nrdAB(ORF203andORF204),nadV
(ORF 228) (Fig. 2), ribose-phosphate pyrophosphokinase (ORF
227), and a thymidylate synthase (ORF 193). NrdAB and NrdDG
represent two distinct classes of ribonucleotide reductases
(RNRs),whichrecycleribonucleotidestosupplydeoxynucleoside
triphosphates (dNTPs) for DNA replication (20). NrdAB belongs
to the class Ia reductases that act under aerobic conditions. In
contrast, NrdDG is a class III reductase that is inactivated by ox-
ygen and is therefore required by cellular organisms under anaer-
obic growth conditions. Facultative anaerobes, like V. cholerae,
rely on a class I enzyme during aerobiosis and a class III enzyme
duringanaerobiosis(20,21).HomologyofNrdABandNrdDsug-
gests that ICP1 RNRs are most closely related to RNRs from
phages, namely, Escherichia phage rv5 (GenBank accession no.
NC_011041), Erwinia phage Ea21-4 (GenBank accession no.
NC_011811),andEnterobacteriaphageFelixO1(GenBankacces-
sion NC_005282). The NrdG of ICP1, on the other hand, shows
the highest homology to V. cholerae O1 strain N16961 NrdG. In
model systems, NrdG catalyzes the activation of NrdD; however,
theFeSclusterofNrdGisﬁrstreducedbyNADPHandﬂavodoxin
reductase (22). It is possible that ICP1 NrdG requires cellular ﬂa-
vodoxin reductase for its activity, since no ﬂavodoxin reductase
homologue was detected in the ICP1 genome, and therefore,
NrdG with similarity to V. cholerae NrdG has been selected for to
permitthisinteractionduringphageinfection.However,theexact
mechanism and function of these proteins during ICP1 infection
of V. cholerae are not known. An intein was identiﬁed in NrdA of
ICP1; this appears to be fairly commonplace, as many phage-
carried RNR genes are interrupted by self-splicing introns or in-
teins (23, 24). Inteins are often found in proteins that are impor-
tant for the survival of the organism, which in turn necessitates
intein maintenance (25). Presumably nrdA contributes to the ﬁt-
ness of ICP1 as it does in phage T4; although nrdA is not essential
in phage T4, nrdA mutants have a reduced burst size (26) and
reduced DNA synthesis (27).
Comparative sequence analysis of ICP1-related phages.
SevenadditionalisolatesofICP1wereisolatedfromstoolsamples
between 2001 and 2006. Compared to ICP1, these seven isolates
showed between 98 and 99.5% nucleotide identity over 95 to
100%ofthelengthoftheirgenomes.Ofthe230CDSsidentiﬁedin
ICP1, 201 were present in all isolates and therefore represent a set
ofcoreproteinsfoundinICP1-relatedphages.Anucleotidealign-
ment of the annotated ICP1 genome with the seven ICP1-related
isolates shows that synteny is conserved with no signiﬁcant ge-
nome rearrangements observed (see Fig. S7 in the supplemental
material). Phylogenetic analysis showed that relatedness was in-
dependentoftheirtimeofisolation(seeFig.S5inthesupplemen-
talmaterial).Forexample,twoofthephagesisolatedin2006were
more closely related to phages isolated in 2001 than to two other
isolates recovered from samples in 2006.
The high conservation of genome synteny and sequence of
ICP1-relatedphagesindicatesthatthisphagehasbeenundercon-
ditionsofstabilizingselectionovertheperiodsampled.Tofurther
investigate this, we identiﬁed synonymous substitutions (silent;
dS) and nonsynonymous substitutions (amino acid altering; dN)
forall230ICP1CDSswithineachoftheICP1-relatedphages.The
average dN/dS ratio per CDS was then calculated to compare the
strengthofpurifyingselectionactingoneachCDS.OftheseCDSs,
120 (52%) remained unchanged, and for 56 CDSs (24%), only
synonymous changes were observed. The average dN/dS ratios for
the 53 CDSs that had both synonymous and nonsynonymous
changes were 1 for all except one (ORF 165, a conserved hypo-
thetical). Thus, 52/53 CDSs that could be analyzed by dN/dS are
undergoing purifying or stabilizing selection, in which changes to
the coding sequence are being selected against (28).
FIG 1 Electron micrograph images of V. cholerae phages isolated from stool samples from cholera patients. (A) ICP1, (B) ICP2, and (C) ICP3. Bars,
100 nm.
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to identify several polymorphic loci that were further analyzed
using PCR in all stool samples (Fig. 3). The ﬁrst locus examined
was a region of 607 bp ﬂanked by 10-bp direct repeats encoding
ORF17andORF18inICP1(Fig.3AandB).ICP1-relatedisolates
from2001and2004(ICP1_2001-AandICP1_2004-A)wereiden-
tical to ICP1 at this locus; however, all phages recovered from
2005 and 2006 (phages ICP1_2005-A and ICP1_2006-A to
ICP1_2006-D) showed a deletion of this region, resulting in the
formation of one contiguous ORF representing an in-frame fu-
sion of ORF 16 and ORF 18. Sequencing of PCR products from
selectedsamplescollectedbetween2008and2010showedthatthe
insertion observed in ICP1, which dominated before 2005, was
present once again, suggesting a selective sweep at this locus. Un-
fortunately, like the majority of CDSs identiﬁed in ICP1, none of
the coding sequences at this locus have homologues to suggest a
reasonforsuchaselectivesweep.AsimilarpolymorphisminORF
182 was detected in ICP1-related phages (Fig. 3C and D). Here, a
region of 264 bp ﬂanked by 10-bp direct repeats was observed in
three ICP1-related phages (ICP1_2004-A, ICP1_2006-C, and
ICP1_2006-D). The deletion allele in ICP1 has a stop codon
downstream,resultinginconversionofalargeORFintotwosmall
ORFs,ORF182andORF183.PCRtoanalyzethispolymorphism
was done on 29 stool samples, and in contrast to what was ob-
servedfortheORF17/18polymorphism(Fig.3A),thereappeared
to be no temporal pattern associated with this polymorphism
(data not shown). The nonessential region was detected in one-
third of stool samples and was found throughout the 10-year pe-
riod. Interestingly, single patient samples often showed both PCR
products corresponding to the indel (insertion and deletion), in-
dicating that a population of ICP1-related phages is mixed at the
genomiclevelatthislocus.Nohomologueswereidentiﬁedforany
of the coding sequences involved in the polymorphism at this
locus.AthirdlocuscorrespondingtothereplacementofORF228
andORF229withaputativecytosine-speciﬁcDNAmethylasewas
observedinICP1-relatedphages(Fig.3EandF).ORF228encodes
a putative ribose-phosphate pyrophosphokinase, and ORF 229
encodes a putative nicotinamide phosphoribosyltransferase
(nadV). Three of the seven sequenced ICP1-related phages
(ICP1_2004-A,ICP1_2006-C,andICP1_2006-D)havethemeth-
FIG 2 Genomic map of ICP1. The numbering below the ORF arrows is the numbering used in the text, tables, and GenBank. The small black arrows indicate
the presence of predicted promoters, and stem loops are predicted transcriptional rho-independent terminators discovered using Mfold (for simplicity, not all
promoters and terminators were shown). The short vertical marks along the genome show distance in kilobases, with a mark placed every 2 kb.
Seed et al.
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methylase or ORF 228 from stool samples, only one additional
stoolsamplefromwhichnophagewererecoveredwaspositivefor
themethylase,whiletheremainder(27/29)werepositiveforORF
228, indicating that these genes involved in nucleotide metabo-
lism are likely selected for over the methylase.
IdentiﬁcationofV.choleraeO1antigenastheICP1receptor.
Previous experiments in which mice were challenged with a mix-
ture of V. cholerae O1 El Tor and ICP1_2006-B resulted in the
generation of phage-resistant V. cholerae isolates having an
O-antigen-deﬁcientphenotype(15).Theseresults,alongwiththe
observation that ICP1 cannot produce plaques on other V. chol-
erae serogroups, indicate that an essential receptor for ICP1 is the
lipopolysaccharide (LPS) O1 antigen. To test this hypothesis, we
carried out a plaque inhibition assay using puriﬁed LPS extracted
from strains representing different serogroups (O1 and O139),
serotypes(O1InabaandOgawa),andaroughmutantlackingthe
O1 antigen. Ten micrograms of puriﬁed LPS from O1 Inaba or
Ogawa strains efﬁciently inhibited plaque formation by ICP1
(Fig. 4). No inhibition was observed when ICP1 was treated with
LPS from V. cholerae O139, the rough mutant lacking the O1
FIG 3 PCR detection of ICP1-related phages in stool samples from cholera patients through analysis of polymorphic regions. Red triangles represent the
indicated direct repeats, and the small black arrows indicate the positions of locus-speciﬁc primers. The sequence of the direct repeats is shown above the red
triangles.(A)SchematicoftheORF17polymorphiclocus.(B)AnexampleoftheORF17polymorphismdetectedinstoolsamplesfromcholerapatientsbyPCR.
(C) Schematic of the ORF 182 polymorphic locus. The asterisk indicates the single nucleotide change found in phages carrying this insertion corresponding to
an STOP ¡ Gln mutation. (D) An example of the ORF 182 polymorphism. (E) Schematic of the ORF 228 polymorphic locus. ORF 228 encodes a putative
ribose-phosphatepyrophosphokinase,whilethedownstreamORFencodesaputativenicotinatephosphoribosyltransferase.Theobservedpolymorphismatthis
locus involves the complete replacement of ORF 228 and nadV with a putative site-speciﬁc DNA methylase. In addition, the nucleotide identity between the
intergenic regions immediately upstream of methylase/ORF228 is indicated. (F) An example of the ORF 228 polymorphism.
FIG4 SDS-PAGEpatternofpuriﬁedLPSaftersilverstaininganditsabilityto
inactivate phage ICP1. Strains used for LPS preparation were as follows:
V. cholerae strain AC53 (wild type [wt]; serotype Ogawa) (lane 1), AC304 (wt;
serotype Inaba) (lane 2), AC304 rfbV::mTn5 (O-antigen mutant) (lane 3),
AC2995(O139)(lane4),andE.coliO26:B6(Sigma)(lane5).Thepositionsof
the fully synthesized LPS with attached O antigen and lipid A core oligosac-
charide (OS) precursor are indicated. The inhibition of ICP1 was determined
by plaque inhibition assays using 10 g of puriﬁed LPS and is indicated as the
average log10 inhibition of two independent assays.
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antigen is a receptor for ICP1 and not the core oligosaccharide.
Furthermore, the results show that the terminal methyl group
present in the O1 antigen of Ogawa serotype strains is not recog-
nized,consistentwiththeobservationthatICP1formsplaqueson
both Inaba and Ogawa serotypes (data not shown).
ICP2 genome. ICP2-related phages were isolated from two
stool samples from cholera patients in 2004 and 2006 and were
detected in four additional stool samples between 2002 and 2007
(Table 2). ICP2 is morphologically a member of the Podoviridae
family(Fig.1B)withacapsidmeasuring60nmlongandshorttails
measuring 13 nm long and 8 nm wide. ICP2 has a 49,675-bp
genome predicted to encode 73 proteins (Table 1). The overall
genomeisorganizedintotwotranscriptionalunitsinwhichORFs
1to25aretranscribedintheorientationoppositethatofORFs26
to 73 (see Fig. S1 in the supplemental material). A unique feature
of the ICP2 genome is that it encodes two proteins (ORF 41 and
ORF 42) to be involved in cobalamin (vitamin B12) biosynthesis.
ORFs 41 and 42 encode putative CobT and CobS cobalt chelatase
subunits, respectively. To our knowledge, CobT/CobS homo-
logues have not been previously observed in phage genomes. Co-
balaminisastructurallycomplexcofactorsynthesizedbybacteria
and is required by enzymes from bacteria, protists, and animals
(29). It is possible that these metabolic enzymes beneﬁt ICP2 by
enhancing the metabolism of the infected bacterial cell, which
could in turn increase phage proliferation. Comparative analysis
of ICP2 and the related phage, ICP2_2006-A, showed these two
are97.8%identicalover97.8%oftheirgenomesatthenucleotide
level. One interesting site of variation was seen between the pre-
dicted phage tail ﬁber proteins of ICP2 and ICP2_2006-A. These
proteinsare54%identicalandshowamuchhigherlevelofamino
acid conservation at the N terminus than at the C terminus. This
indicatesthattheremaybehostrangedifferencesbetweenthetwo
phages, although we have not identiﬁed any thus far.
ICP3genome.ICP3wasrecoveredfromacholerapatientstool
sample from 2007, and four additional ICP3-related isolates were
recovered from patient samples between 2007 and 2010, but not
from patient samples before this (Table 2). ICP3 is morphologi-
callyamemberofthePodoviridae(Fig.1C)withacapsidmeasur-
ing 60 nm long and short tails measuring 13 nm long by 8 nm
wide. ICP3 is morphologically indistinguishable from coliphage
T7 and Vibrio phage III of the typing set of Mukerjee (30). Phages
ofthismorphologicaltypehaverepeatedlybeenisolatedandseem
to be very common (31). The 39,162-bp genome has 54 predicted
CDSs, all transcribed from the same strand (see Fig. S2 in the
supplemental material). Genomic analysis using CoreGenes (32)
demonstrated that ICP3 has 43% of its proteins in common with
T7, placing ICP3 as a member of the “T7-like viruses” within the
subfamily Autographivirinae (33). Functions could be assigned to
almost half of the genes based on the similarity of the predicted
products to known proteins (Table 1).
T7-like viruses utilize the host RNA polymerase (RNAP) for
expression of early genes, which include a phage-borne RNAP
(gene 1) (34). Middle and late regions are transcribed by the
phage-borne RNAP, which recognizes conserved phage-speciﬁc
promoters that are related to a 23-bp consensus sequence (35).
Fourteen phage-speciﬁc promoters were identiﬁed in ICP3, and
the consensus sequence shows sequence similarity to the T7 pro-
moter consensus sequence (see Fig. S4 in the supplemental mate-
rial). Speciﬁcally, the region from positions 7t o6 is identical
to the T7 consensus promoter sequence, while the region from
positions17to8isuniquetoICP3comparedtoT7andother
T7-like viruses, consistent with the ﬁnding that this region is re-
sponsible for phage-speciﬁc promoter recognition (35).
ComparativesequenceanalysisofICP3-relatedphages.Four
ICP3-related isolates recovered from stool samples between 2007
and 2010 were sequenced and compared to ICP3. These isolates
wereremarkablysimilartoICP3,sharingbetween99.6and99.8%
nucleotide identity over 99.3 to 99.8% of their genome. A nucle-
otide alignment of the annotated ICP3 genome with the four
ICP3-related isolates showed that the genomes are collinear, with
nosigniﬁcantrearrangementsobserved(seeFig.S3inthesupple-
mental material).
Weidentiﬁedsynonymousandnonsynonymoussubstitutions
inICP3-relatedphagesforall54CDSsinICP3.Seventeenofthese
CDSs(31%)hadnomutationsinanyisolatesrelativetoICP3,and
18 CDSs (33%) had only synonymous changes. The dN/dS ratios
for 18 of 19 CDSs that had both synonymous and nonsynony-
mous changes were 1 and thus are undergoing purifying or sta-
bilizingselection.Theoneexceptiontothiswasgp12,whichhasa
dN/dS value of 1, indicating positive or diversifying selection
(28). In T7, the initial interaction with the bacterium is mediated
by tail ﬁbers (gp17) binding to LPS; subsequent interactions be-
tween one or both of the gp11 and gp12 tail proteins with un-
knowncellsurfacecomponentsmayservetosituatethephagetoa
site where a successful infection can occur (36). The only CDS
foundtobeundergoingpositiveselectioninICP3wastheT7gp12
homologue, which may indicate that this protein is prone to evo-
lutionary diversiﬁcation to enhance the host range of this phage.
In total, 50 of the 54 CDSs present in ICP3 were present in all
ICP3-related isolates, and phylogenetic analysis of ICP3-related
phages based on this shared core genome revealed that isolates
recovered in 2007 and 2008 are more closely related to each other
thanisolatesrecoveredin2009are(seeFig.S6inthesupplemental
material).
DISCUSSION
The ecological factors supporting or promoting seasonal epidem-
ics in areas where cholera is endemic, such as Bangladesh, are a
topic of intense interest. A factor previously identiﬁed as having a
role in the occurrence of V. cholerae outbreaks are lytic phages (5,
13). An interesting feature of lytic phages is that, similar to envi-
ronmental factors, such as water temperature or rainfall amounts
(37), phage may modulate the population of V. cholerae in the
environment,thusimpactingtheoccurrenceofanoutbreak;how-
ever, uniquely, these phages also travel with V. cholerae into the
human host and are shed at appreciable amounts by infected pa-
tients, where like V. cholerae they could be spread to others via
fecal-oral transmission. The impact of these phages on infectivity
has only recently begun to be addressed (15, 16), and much more
remains to be elucidated regarding the potential impact these
phages have on V. cholerae both in the environment and in an
infected host. We set out to characterize lytic phages collected
from cholera patients and identiﬁed a unique phage type that is
pervasive in all cholera patients from an area where cholera is
endemic.
Phage genomes frequently contain a majority of novel genetic
sequences of unknown function (23), and ICP1 is no exception,
with 75% of its CDSs having no sequence similarity to any pro-
teins seen thus far. Seven additional ICP1-related isolates from
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were sequenced and compared to ICP1, which revealed a stable
ICP1 genome. Stability is suggested from the high level of nucle-
otideidentity,lackofinversionsandothermajorrearrangements,
andthestabilizingselectioninferredforvirtuallyallgenesharbor-
ingsynonymousandnonsynonymousmutations.Indelswereob-
served, and these included a small number of polymorphic loci
that appear to frequently undergo alterations, two of them by
recombination between 10-bp direct repeats. We were unable to
identify any synonymous or nonsynonymous mutations that ap-
peared in an isolate and were then carried forward in time, sug-
gesting that these isolates represent a sampling of a large stable
population of ICP1-related phages present in patients and pre-
sumably in the local environment in Dhaka, Bangladesh.
For several stool samples, we observed single-locus variants of
ICP1 using PCR, in addition to the presence of the unrelated
phages ICP2 and ICP3. In a previous study (16), it has similarly
been observed that multiple phage types can be excreted by a sin-
gle patient. These results parallel results for V. cholerae isolates
from cholera patients (also in Dhaka, Bangladesh) in which in-
trapatient variation of V. cholerae dominated: 89% of stool sam-
ples had V. cholerae isolates with distinct genotypes (38). Taken
together, these results suggest that both within and between chol-
era patients, the bacterial and phage burden during symptomatic
diseaseisdiverse.Selectedisolatesmayrepresentonlyafractionof
the genomic diversity present during an outbreak. The relative
stabilityoftheICP1genomeovertimeanditsubiquitouspresence
in cholera patients suggest that ICP1 is extremely well adapted to
itshost,speciﬁcallytopathogenicV.choleraeO1,andthatthereis
signiﬁcant selective pressure to maintain this particular genome
structure.
LyticphagefromaquaticenvironmentsinDhaka,Bangladesh,
aswellasfromcholerapatientstoolsamplesattheICDDR,Bhave
been isolated and characterized by host range, electron micros-
copy, and restriction endonuclease cleavage patterns of puriﬁed
phage genomes (5, 13). This work has identiﬁed the presence of
multiplephagetypes,includingphageJSF4(5).Thoughsequence
data are lacking, based on the KpnI restriction proﬁle of phage
JSF4 presented in supplemental data by Faruque et al. (13), we
believe that JSF4 may be an ICP1-related isolate. JSF4 was recov-
ered from cholera patient stool samples collected at the ICDDR,B
during an epidemic that began in August 2004; during that study
period, it was observed that as the epidemic progressed, an in-
creasingly higher proportion of patients were observed to excrete
JSF4 in their stool samples (13). JSF4 was also recovered from
patientsamplesbetween2004and2007,andagainitwasobserved
thatthisphagewasmorefrequentlyisolatedduringthelaterstages
ofanepidemic(16).Inbothofthesestudies,patientsampleswere
collected in which no phage were detected (for example, the per-
centage of patients excreting lytic phages ranged from ~5 to
~100% during the 12-week epidemic [13]). Assays for phages in
stool samples in these studies were conducted by looking for
plaque formation following inoculation of ﬁlter-sterilized stool
samples with recipient V. cholerae strains. We also assayed for
plaque formation, but in addition, we used PCR to more sensi-
tively detect the presence of phages recovered in this study and
observed that all of the stool samples had ICP1 and roughly half
had at least one other phage.
JSF4 titers in stool samples from cholera patients have been
reportedtobebetween4.0102to1.1108PFU/ml(13)and1.8
 103 to 5.7  107 PFU/ml (16). Despite seemingly high levels of
lyticphageinthestoolsamples,V.choleraeO1isolatedfromstool
samples in which lytic phage were present are susceptible to lysis
by the phage recovered from the same stool sample (this was ob-
served with JSF4 [13, 16] and with ICP1_2006-B, ICP1_2006-C,
and ICP_2006_D [15]). This is consistent with our ﬁnding that
the receptor for ICP1 is the O1 antigen of V. cholerae. While LPS
mutantslackingtheO1antigendominateininvitroculturescon-
tainingJSF4(16)andcanbeisolatedfollowinginvivocoinfection
ofV.choleraeandICP1_2006-Binmice(15),suchphage-resistant
O1 antigen-deﬁcient bacteria would probably not dominate in
human stool samples, as O1 antigen mutants are attenuated for
virulence (16, 39, 40). This suggests that O1 antigen-deﬁcient
V. cholerae would be lost from the natural life cycle (41), because
the ﬁtness advantage to remaining O1 positive and virulent in
humans is greater than the ﬁtness advantage conferred by muta-
tional escape from phages like ICP1.
The pervasiveness of ICP1-related phages in cholera patients
treated at the ICDDR,B brings into question the life cycle of these
phages;onecouldspeculatethatICP1maybecapableofestablish-
inglysogeny.BioinformaticsanalysisofeightICP1-relatedphages
did not reveal anything at the genetic level that suggests establish-
ment of classic lysogeny; for example, these phages appear to lack
integrasesandexcisionases.Despitethis,usingPCR,wehavebeen
able to detect the transient presence of the ICP1 genomic DNA
inside passaged bacterial colonies following ICP1 infection; how-
ever,thephagegenomedoesnotappeartobestablymaintainedin
V. cholerae under the conditions tested (data not shown). A sim-
ilar suggestion has been made for JSF4 (5, 14).
Finally, we also isolated and characterized two other unrelated
types of phages from cholera patients in this study. ICP2-related
phages were the least prevalent in clinical samples, and like ICP1,
they were found to be genetically diverse and distinct from other
sequenced phages in the databases. ICP3-related phages are T7-
like and appeared in 2007 in patients at the ICDDR,B. In contrast
to ICP1, both ICP2 and ICP3-related phages are not speciﬁc to
V. cholerae O1, which is consistent with their less frequent isola-
tion from stool samples from cholera patients, as they are not
reliant on the most clinically dominant agent of cholera for their
propagation.
MATERIALS AND METHODS
Strains and growth conditions. V. cholerae strains used in this study are
listed in Table S2 in the supplemental material. Strains were grown on
Luria-Bertani (LB) agar or in LB broth at 37°C with 100 g/ml strepto-
mycin (SM) with the exceptions of strain AC304 rfbV::mTn5, which was
grown in the presence of 25 g/ml kanamycin and strain CR034-24,
which was grown in the absence of antibiotics. To plate phages, strain
AC53 was grown to mid-exponential phase (optical density at 600 nm
[OD600] of ~0.3) and added to phage that were allowed to adsorb for
10 min at room temperature; the mixture was added to LB soft agarose
(0.5%) and overlaid onto plates containing LB agar plus SM. The plates
were incubated overnight at 37°C.
Phage isolation and detection in clinical specimens. Phages
ICP1_2006-B, ICP1_2006-C, and ICP1_2006-D were isolated previously
and referred to as phages EN159, EN182, and EN191, respectively (15).
ICP1 was isolated from a stool sample collected at the ICDDR,B in 2001
(S. Merrell and A. Camilli, unpublished data). Stool specimens were col-
lected and stored from previous studies (42, 43). All other phages de-
scribed in this study were isolated from stool samples as follows: ~100l
stoolsamplewasaddedto10mlofLBplusstrainAC53(startingOD600of
0.05), and the mixture was allowed to incubate overnight at 37°C. The
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nique described above for detection of plaques. Phages were subjected to
three rounds of plaque puriﬁcation before being grown to a high titer for
DNA isolation. For PCR, total DNA was extracted from 100-l stool
samples using the DNeasy blood and tissue kit (Qiagen). Primers for the
ampliﬁcationofV.cholerae16SDNA(44)wereusedasapositivecontrol.
Select PCR products were conﬁrmed by sequencing.
Phage DNA isolation and sequencing. A modiﬁed version of the
phage DNA extraction protocol described by Sambrook and Russell (45)
was used. High-titer lysates were treated with benzonase endonuclease
(Sigma) at 37°C; EDTA was omitted from the protocol. Paired-end Illu-
mina libraries were created for each phage as previously described (46).
Bar-coded adapters used (e.g., BC1a and BC1b) are listed in Table S2 in
thesupplementalmaterial.Eachpuriﬁed,bar-codedsamplewassubjected
to15cyclesofPCRampliﬁcationusingprimersOLJ139andOLJ140(46).
Sequencing was conducted at the Tufts University Core facility using an
Illumina genome analyzer II.
Sequence analysis. Genomes were assembled with Velvet (47). Per-
base coverage values ranged from 1,000 to 7,000 times. Detailed manual
analysis was conducted for ICP3, ICP2, and ICP1. Open reading frames
were identiﬁed using Kodon (Applied Maths, Austin, TX). GeneMark
.hmm (48) was used in conjunction with Kodon for ICP1. Batch BLAST
(http://greengene.uml.edu/programs/NCBI_Blast.html) was used to
identify homologues. Promoters were identiﬁed on the basis of sequence
similarity to E. coli consensus 70 promoter: TTGACA(N15-17)TATAAT,
immediately upstream of an annotated gene. Rho-independent termina-
tors were identiﬁed using Mfold (49). For phage ICP3, phage-speciﬁc
promoters were discovered using PHIRE (50), and WebLogo (51) was
used to generate a sequence logo for the consensus promoter.
tRNAscan-SE v 1.21 (52) and Aragorn (53) were used to search the ge-
nomes for phage-encoded tRNA genes. Genomes were compared at the
nucleotide level using the progressiveMauve algorithm (54). CoreGenes
wasusedforcomparisonsattheproteomiclevel(32).ICP1-related,ICP2-
related, and ICP3-related isolates were submitted for automated annota-
tionaspartofapilotPhageGenomesAutomaticAnnotationbyR.Brister
(NCBI).
Genomicselectionlevels.ForeveryannotatedCDSinICP1andICP3,
weusedBLASTtoidentifyhomologousregionsofatleast75%identityfor
every related phage isolate. Homologous regions were aligned using
ClustalW (http://www.ebi.ac.uk/Tools/msa/clustalw2/). We determined
the dN, dS, and dN/dS (55) for every pair and the average values for each
ORF.
Phylogeneticanalysis.GRIMM(56)foundnomajorrearrangements
between the progenitor phage and the respective related isolates. Every
aligned ORF found above that was present in every phage was concate-
nated into a whole-genome alignment of ORFs. The resulting contiguous
sequence was provided as input to MrBayes (http://mrbayes.csit.fsu.edu
/index.php),aprogramfortheBayesianestimationofphylogeny.Figures
of each tree were generated using Figtree v1.3.1 (http://tree.bio.ed.ac.uk
/software/ﬁgtree/).
Transmission electron microscopy. High-titer phage stocks were
sedimented for1ha t25,000  g using a Beckman (Palo Alto, CA) J2-21
high-speed centrifuge and a JA-18.1 ﬁxed-angle rotor. Phages were
washedtwiceinammoniumacetatebuffer(0.1M,pH7.0).Puriﬁedphage
particlesweredepositedon3-mmcarbon-coatedcoppergridsandstained
with 2% phosphotungstate at pH 7.2 (ICP2 and ICP3) or 2% uranyl
acetate at pH 4.5 (ICP1) and examined with a Phillips EM 300 electron
microscope. Magniﬁcation was monitored using T4 phage tails.
LPSextractionandplaqueinhibitionassays.Cellsurfacepolysaccha-
rides were prepared and visualized as described recently (57). The ability
ofpuriﬁedLPStoneutralizeplaqueformationwasdeterminedbymixing
104 PFU of ICP1 with 10 g of puriﬁed LPS in 600 l of LB plus 10 mM
CaCl2 f o r1ha t37°C. Serial dilutions of this mixture were then plated
using the soft-agar overlay method described earlier.
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